Anna Ermacora

26 papers receiving 558 citations

Peers

Anna Ermacora
Comparison fields: 5 of 56
  • Hematology 205
  • Oncology 288
  • Genetics 89
  • Hepatology 59
  • Emergency Medicine 36
Replace Entezam Sahovic with:
Entezam Sahovic United States
Ted Gooley United States
Radovan Sašo United Kingdom
J.P. Laporte France
Seung‐Hwan Shin South Korea
Jurjen Versluis Netherlands
Theodora Foukaneli United Kingdom
Pierre Brousset France
Jonathan P. Kerr United Kingdom
Sam Penza United States
Anna Ermacora relative to Entezam Sahovic United States Entezam Sahovic's profile →
Citations per field
00.5×2.6×
Entezam Sahovic · 1×
Citations per year

Countries citing papers authored by Anna Ermacora

Since Specialization
Citations

This map shows the geographic impact of Anna Ermacora's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Ermacora with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Ermacora more than expected).

Fields of papers citing papers by Anna Ermacora

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Ermacora. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Ermacora. The network helps show where Anna Ermacora may publish in the future.

Co-authors

The 25 scholars most cited alongside Anna Ermacora, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Anna Ermacora Line = papers co-authored together Anna Ermacora links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.

#Work
1 199999
2 199974
3 199763
4 199943
5
Rituximab for the treatment of type II mixed cryoglobulinemia.
199941
6 200037
7 200231
8
P-glycoprotein (PGP), and not lung resistance-related protein (LRP), is a negative prognostic factor in secondary leukemias.
199830
9 201826
10 200023
11
Effect of fludarabine and arabinosylcytosine on multidrug resistant cells.
199722
12 199818
13 199915
14 201611
15 201210
16
Lamivudine for the prevention of hepatitis B virus reactivation during autologous stem cell transplantation. A case report.
20008
17
Overcoming PGP-related multidrug resistance. The cyclosporine derivative SDZ PSC 833 can abolish the resistance to methoxy-morpholynil-doxorubicin.
19966
18 20215
19 20204
20 20204

About Anna Ermacora

Anna Ermacora is a scholar working on Hepatology, Genetics, Oncology, Hematology and Public Health, Environmental and Occupational Health, having authored 27 papers that have together received 579 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (12 papers), Acute Lymphoblastic Leukemia research (7 papers), Hepatitis C virus research (6 papers), Chronic Lymphocytic Leukemia Research (5 papers), Lymphoma Diagnosis and Treatment (4 papers), Pharmacological Effects and Toxicity Studies (3 papers), Hepatitis B Virus Studies (3 papers) and Systemic Lupus Erythematosus Research (3 papers). The work is most often cited by research in Hematology (205 citations), Oncology (288 citations), Genetics (89 citations), Hepatology (59 citations) and Emergency Medicine (36 citations). Anna Ermacora has collaborated with scholars based in Italy, Netherlands and Ukraine. Frequent co-authors include Michele Baccarani, Mariagrazia Michieli, Daniela Damiani, Paola Masolini, Angela Michelutti, Domenico Russo, Donatella Raspadori, Renato Fanin, Giuseppe Visani and R.J. Scheper. Their work appears in journals such as British Journal of Haematology, Hematological Oncology, International Journal of Radiation Oncology*Biology*Physics, Leukemia Research and Leukemia.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026